✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Amicus Therapeutics Inc

Common Name
Amicus Therapeutics
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
499
Ticker
FOLD
Exchange
NASDAQ/NMS
Description
Amicus Therapeutics Inc. is a biotechnology company dedicated to discovering, developing, and commercializing therapies for rare and orphan diseases. It focuses on addressing unmet medical needs in ge...

Amicus Therapeutics's Revenues Data

Explore Amicus Therapeutics's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
634,210,000a
528,295,000a
399,356,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Amicus Therapeutics’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Amicus Therapeutics's 10-K 2025